Dipeptidyl peptidase-4 (DPP-4) inhibitors have shown favorable pleiotropic effects on atherosclerosis to improve endothelial cell function, which is essential for maintaining vascular integrity and preventing atherosclerotic progression [13]. Here, DPP4 is linked to atherosclerosis.